Alongside this, baicalin could improve the anti-tumor immune function, down-regulating PD-L1 expression and upregulating the CD4+ and CD8+ T cell ratio, thereby improving the tumor immune microenvironmen (Yang et al., 2020). The gene discussed is CD8A; the disease is neoplasm.